Development and characterization of [47Sc]Sc-NOTA-trastuzumab for targeted radiotherapy in primary and metastatic HER2 + breast cancer.

Saved in:
Bibliographic Details
Title: Development and characterization of [47Sc]Sc-NOTA-trastuzumab for targeted radiotherapy in primary and metastatic HER2 + breast cancer.
Authors: Song PN; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA; Graduate Biomedical Sciences, The University of Alabama at Birmingham, Birmingham, USA., Cingoranelli SJ; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA; Department of Chemistry, The University of Alabama at Birmingham, Birmingham, USA., Sridhar S; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA., Houson HA; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA; Department of Chemistry, The University of Alabama at Birmingham, Birmingham, USA., Gallegos CA; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA; Department of Biomedical Engineering, The University of Alabama at Birmingham, Birmingham, USA., Watts LB; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA., Bartels JL; Department of Chemistry, The University of Alabama at Birmingham, Birmingham, USA., Willey CD; Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, USA; O'Neal Comprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, USA., Lapi SE; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA; Department of Chemistry, The University of Alabama at Birmingham, Birmingham, USA; O'Neal Comprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, USA. Electronic address: lapi@uab.edu., Sorace AG; Department of Radiology, The University of Alabama at Birmingham, Birmingham, USA; Department of Biomedical Engineering, The University of Alabama at Birmingham, Birmingham, USA; O'Neal Comprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, USA. Electronic address: asorace@uabmc.edu.
Source: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2026 Jul 21; Vol. 202, pp. 119736. Date of Electronic Publication: 2026 Jul 21.
Publication Type: Journal Article
Journal Info: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1950-6007 (Electronic) Linking ISSN: 07533322 NLM ISO Abbreviation: Biomed Pharmacother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1950-6007
DOI:10.1016/j.biopha.2026.119736